Related Experiment Video
Updated: May 17, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Antineoplastic activities of Gd@C₈₂(OH)₂₂ nanoparticles: tumor microenvironment regulation
Yiye Li1, Yanhuan Tian, Guangjun Nie
1National Center for Nanoscience and Technology (NCNST), CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, Beijing 100190, China.
Abstract:
Malignant tumors are complex organs consisting of tumor cells and their microenvironment. Increasing evidence has shown that the tumor microenvironment is critical to the initiation and progression of tumors. Rational design of tumor therapies via targeting the tumor microenvironment to inhibit tumor growth is thus becoming a consensus strategy. Gd@C(82)(OH)(22) nanoparticles, as novel endohedral hydroxylated metallofullerenes, have been demonstrated to be a potent antitumor nanomedicine via targeting multiple factors in the tumor microenvironment. Gd@C(82)(OH)(22) nanoparticles possess excellent biocompatibility and remarkable antineoplastic activity, as a result not of direct tumor cytotoxicity but of their diverse biological effects, including antioxidation, immune activation, angiogenesis inhibition, imprisoning cancer cells, and reversal of drug-resistance. In this article, we summarize the unique nanoscale physiochemical properties and the antineoplastic activities of Gd@C(82)(OH)(22) nanoparticles, and focus on the mechanisms underlying their regulation of the tumor microenvironment.
Insights
Gd@C(82)(OH)(22) nanoparticles show potent antitumor effects by modulating the tumor microenvironment. These novel hydroxylated metallofullerenes offer biocompatibility and diverse biological activities for cancer therapy.
Area of Science:
- Nanomedicine
- Oncology
- Biochemistry
Background:
- Tumor microenvironment plays a critical role in cancer initiation and progression.
- Targeting the tumor microenvironment is a key strategy for developing effective cancer therapies.
- Gd@C(82)(OH)(22) nanoparticles represent a novel class of endohedral hydroxylated metallofullerenes.
Purpose of the Study:
- To summarize the physiochemical properties and antitumor activities of Gd@C(82)(OH)(22) nanoparticles.
- To elucidate the mechanisms by which these nanoparticles regulate the tumor microenvironment.
- To highlight their potential as a nanomedicine for cancer treatment.
Main Methods:
- Review of existing literature on Gd@C(82)(OH)(22) nanoparticles.
- Analysis of their nanoscale physiochemical properties.
- Investigation of their biological effects on the tumor microenvironment.
Main Results:
- Gd@C(82)(OH)(22) nanoparticles exhibit excellent biocompatibility and significant antineoplastic activity.
- Their efficacy stems from diverse biological effects, not direct cytotoxicity.
- Key mechanisms include antioxidation, immune activation, angiogenesis inhibition, cancer cell trapping, and overcoming drug resistance.
Conclusions:
- Gd@C(82)(OH)(22) nanoparticles are a promising nanomedicine for cancer therapy.
- Their ability to modulate the tumor microenvironment underlies their therapeutic potential.
- Further research into their mechanisms can optimize their clinical application.
Related Concept Videos
The Tumor Microenvironment
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Mitogens and the Cell Cycle
